Mechanisms of action of atypical antipsychotic drugs: a critical analysis

Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

Rupniak, N. M. J., Kilpatrick, G. J., Hall, M. D., et al. (1984) · Psychopharmacology · doi:10.1007/bf00431458 · Cited by 69

The role of excitatory amino acids in neuropsychiatric illness

Javitt, D. C., & Zukin, S. R. (1990) · Journal of Neuropsychiatry · doi:10.1176/jnp.2.1.44 · Cited by 69

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol of clozapine

Gianutsos, G., & Moore, K. E. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90452-0 · Cited by 68

Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial

Min, S. K., Rhee, C. S., Kim, C. E., et al. (1993) · Yonsei Medical Journal · doi:10.3349/ymj.1993.34.2.179 · Cited by 68

Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels

Roth, B. L., & Ciaranello, R. D. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90093-w · Cited by 68

Motor and mental aspects of acute extrapyramidal syndromes

Casey, D. E. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05826.x · Cited by 68

Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.

Janowsky, A. J., Neve, K. A., Kinzie, J. M., Taylor, B., de Paulis, T., & Belknap, J. K. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11150-6 · Cited by 68

The effects of clozapine on neurocognition: an overview.

Goldberg, T. E., & Weinberger, D. R. (1994) · PubMed · Cited by 68

Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol

Seeger, T., Thal, L. J., & Gardner, E. L. (1982) · Psychopharmacology · doi:10.1007/bf00435275 · Cited by 67

Analysis of the D4 Dopamine Receptor Gene Variant in an Italian Schizophrenia Kindred

Macciardi, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040032004 · Cited by 67

Electrochemistry in Vivo: Application to CNS Pharmacologya

Lane, R. F., & Blaha, C. D. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb23603.x · Cited by 66

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

Casey, D. E. (1992) · Psychopharmacology · doi:10.1007/bf02244960 · Cited by 65

Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies

K�hler, C., Haglund, L., Ögren, S. O., & �ngeby, T. (1981) · Journal of Neural Transmission · doi:10.1007/bf01249601 · Cited by 64

Clozapine use in diffuse Lewy body disease

Chacko, R. C., Hurley, R. A., & Jankovic, J. J. (1993) · Journal of Neuropsychiatry · doi:10.1176/jnp.5.2.206 · Cited by 63

Dopamine D4 receptor variants in unrelated schizophrenic cases and controls

Sommer, S. S., Lind, T. J., Heston, L. L., & Sobell, J. L. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480207 · Cited by 63

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

See, R. E., Toga, A. W., & Ellison, G. (1990) · Journal of Neural Transmission · doi:10.1007/bf01245166 · Cited by 60

Glutamate in schizophrenics and healthy controls

Gattaz, W. F., Gattaz, D., & Beckmann, H. (1982) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00343292 · Cited by 60

The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats.

Impérato, A., & Angelucci, L. (1989) · PubMed · Cited by 60

The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis

Ichikawa, J., & Meltzer, H. Y. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90033-3 · Cited by 59

A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia

McCreadie, R. G., Todd, N. A., Livingston, M., et al. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06300.x · Cited by 59

Metoclopramide: Antipsychotic efficacy of a drug lacking potency in receptor models

Stanley, M., Lautin, A., Rotrosen, J., Gershon, S., & Kleinberg, D. L. (1980) · Psychopharmacology · doi:10.1007/bf00433055 · Cited by 59

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

Svensson, A. I., Carlsson, A., & Carlsson, M. L. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250961 · Cited by 59

Clozapine: Selective Labeling of Sites Resembling 5HT6 Serotonin Receptors May Reflect Psychoactive Profile

Glatt, C. E., Snowman, A. M., Sibley, D. R., et al. (1995) · Molecular Medicine · doi:10.1007/bf03401577 · Cited by 58

Schizophrenia and the D1 receptor: Focus on negative symptoms

Lynch, M. R. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90102-k · Cited by 58

Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat

Skarsfeldt, T., & Perregaard, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90067-g · Cited by 58

RISPERIDONE IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS: AN INTERNATIONAL DOUBLE-BLIND PARALLEL-GROUP STUDY VERSUS HALOPERIDOL.

Müller-Spahn, F. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00048 · Cited by 58

Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

Ikeguchi, K., & Kuroda, A. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190411 · Cited by 57

Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area

Bowery, B. J., Rothwell, L. A., & Seabrook, G. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13161.x · Cited by 57

Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred

Barr, C. L., Kennedy, J. L., Lichter, J. B., Tol, H. H. M. V., Wetterberg, L., Livak, K., & Kídd, K. K. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480409 · Cited by 57

Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia: Serotonin-Dopamine Interactions as a Target for Treatment

Kahn, R. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820200009001 · Cited by 56

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

Sumiyoshi, T., Kido, H., Sakamoto, H., et al. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90158-9 · Cited by 56

Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine

Ramírez, O. A., & Wang, R. Y. (1986) · Brain Research · doi:10.1016/0006-8993(86)91411-3 · Cited by 55

Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat

Ögren, S. O., Archer, T., & Johansson, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90209-4 · Cited by 54

Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy

Robertson, A., & MacDonald, C. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90137-0 · Cited by 54

Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons

Hollerman, J. R., Abercrombie, E. D., & Grace, A. A. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90168-2 · Cited by 53

Cross-sensitization between foot shock stress and enkephalin-induced motor activity

Kalivas, P. W., Richardson-Carlson, R., & Orden, G. V. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90268-4 · Cited by 53

Anti-glutamatergic effects of clozapine

Lidsky, T. I., Yablonsky-Alter, E., Zuck, L., & Banerjee, S. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90370-z · Cited by 53

The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment

Peacock, L., Lublin, H., & Gerlach, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94059-7 · Cited by 53

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

Calderon, S. F., Sanberg, P. R., & Norman, A. B. (1988) · Brain Research · doi:10.1016/0006-8993(88)91584-3 · Cited by 52

Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile

Ögren, S. O., & Archer, T. (1994) · Psychopharmacology · doi:10.1007/bf02249327 · Cited by 50

Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study

Busatto, G. F., Pilowsky, L. S., Kerwin, R. W., Costa, D. C., Ell, P. J., & Verhoeff, N. P. L. G. (1995) · Psychopharmacology · doi:10.1007/bf02245098 · Cited by 50

Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia

Davidson, M., Kahn, R., Stern, R. G., Hirschowitz, J., Apter, S. H., Knott, P. J., & Davis, K. L. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90017-b · Cited by 50

Scopolamine attenuates haloperidol-induced c-fos expression in the striatum

Guo, N., Robertson, G. S., & Fibiger, H. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)91358-l · Cited by 50

Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment

Youngren, K. D., Moghaddam, B., Bunney, B. S., & Roth, R. H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90704-8 · Cited by 49

The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings.

Arana, G. W., Ornsteen, M., Kanter, F., Friedman, H. L., Greenblatt, D. J., & Shader, R. I. (1986) · PubMed · Cited by 49

Modulatory effect of clozapine on levodopa response in parkinson's disease: A preliminary study

Gómez-Arévalo, G., & Gershanik, O. S. (1993) · Movement Disorders · doi:10.1002/mds.870080317 · Cited by 47

Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block

Chen, J., Paredes, W. M., & Gardner, E. L. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90209-c · Cited by 47

Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase

Gnegy, M. E., Lucchelli, A., & Costa, E. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501426 · Cited by 46

Seroquel (ICI 204 636), a putative “atypical” antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters

Wetzel, H., Szegedi, A., Hain, C., Wiesner, J., Schlegel, S., & Benkert, O. (1995) · Psychopharmacology · doi:10.1007/bf02246165 · Cited by 46

A controlled dose‐ranging study of remoxipride and haloperidol in schizophrenia ‐ a Canadian multicentre trial

Lapierre, Y. D., Nair, N., Chouinard, G., Awad, A. G., Saxena, B., Jones, B., McClure, D. J., Bakish, D., Max, P., Manchanda, R., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05293.x · Cited by 46

The Effect of the Partial Dopamine Agonist Terguride on Negative Symptoms in Schizophrenics

Olbrich, R., & Schanz, H. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1017021 · Cited by 45

Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary

Jaber, M., Tison, F., Fournier, M.-C., & Bloch, B. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90206-2 · Cited by 45

Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: Implications for the pathogenesis of neuroleptic-induced movement disorders

Auchus, A. P., & Pickel, V. M. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90106-z · Cited by 44

Pharmacologic properties of (?)-3PPP (preclamol) in man

Tamminga, C. A., Cascella, N. G., Lahti, R. A., Lindberg, M., & Carlsson, A. (1992) · Journal of Neural Transmission · doi:10.1007/bf01244730 · Cited by 44

Comparative Psychotropic Effects of Metoclopramide and Prochlorperazine in Normal Subjects

Nakra, B. R. S., Bond, A. J., & LADER, M. H. (1975) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1975.tb02368.x · Cited by 44

Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats

Gainetdinov, R. R., Grekhova, T. V., Sotnikova, T. D., & Rayevsky, K. S. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90125-2 · Cited by 43

Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine

Prinssen, E. P. M., Ellenbroek, B. A., & Cools, A. R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90041-8 · Cited by 43

Neuroleptics have identical potencies in human brain limbic and putamen regions

Seeman, P. M., & Ulpian, C. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90452-1 · Cited by 43

Effects of prazosin on the dopaminergic neurotransmission in rat brain

Sommermeyer, H., Frielingsdorf, J., & Knorr, A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00062-p · Cited by 43

Functional Coupling of Human D2, D3, and D4 Dopamine Receptors in HEK293 Cells

McAllister, G., Knowles, M. R., Ward-Booth, S. M., et al. (1995) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899509045220 · Cited by 42

Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol

Karbe, H., Wienhard, K., Hamacher, K., Huber, M., Herholz, K., Coenen, H. H., St�cklin, G., L�venich, A., & Heiss, W. (1991) · Journal of Neural Transmission · doi:10.1007/bf01250702 · Cited by 42

Clozapine: A Hypothesised Mechanism for its Unique Clinical Profile

Bunney, B. S. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296864 · Cited by 42

Interaction of clozapine with the histamine H3 receptor in rat brain

Rodrigues, A. A., Jansen, F. P., Leurs, R., Timmerman, H., & Prell, G. D. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14934.x · Cited by 41

Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol

Merchant, K., & MILLER, M. A. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90234-8 · Cited by 41

Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.

Coward, D. M., Dixon, K., Enz, A., et al. (1989) · PubMed · Cited by 41

Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats

Gattaz, W. F., Schummer, B., & Behrens, S. (1994) · Journal of Neural Transmission · doi:10.1007/bf01294789 · Cited by 40

Clozapine Treatment of Parkinsonism with Psychosis

Lew, M., & Waters, C. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06743.x · Cited by 40

Expression of the Proneurotensin Gene in the Rat Brain and Its Regulation by Antipsychotic Drugsa

Merchant, K., Dobie, D. J., & Dorsa, D. M. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb27339.x · Cited by 39

Behavioral profile of raclopride in agonistic encounters between male mice

Aguilar, M. A., Miñarro, J., Pérez-Iranzo, N., & SIMON, V. M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90185-6 · Cited by 38

Haloperidol but Not Clozapine Increases Neurotensin Receptor mRNA Levels in Rat Substantia Nigra

Watson, C. B., Watson, M. A., Murray, K. D., Isackson, P. J., & Richelson, E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03631.x · Cited by 38

Prazosin, a specific alpha1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients

Hommer, D. W., Zahn, T. P., Pickar, D., & van Kammen, D. P. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90068-4 · Cited by 38

Zacopride in Schizophrenia: A Single-blind Serotonin Type 3 Antagonist Trial

Faustman, W. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090079013 · Cited by 37

Structure-Activity Relationships of the Butyrophenones and Diphenylbutylpiperidines

Janssen, P. A. J., & Bever, W. F. M. V. (1978) · Springer eBooks · doi:10.1007/978-1-4613-4042-3_1 · Cited by 36

Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements

Knable, M. B., Hyde, T. M., Egan, M. F., Tosayali, M., Wyatt, R. J., & Kleinman, J. E. (1994) · Brain Research · doi:10.1016/0006-8993(94)90081-7 · Cited by 36

Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.

WOLK, S., & Douglas, C. J. (1992) · PubMed · Cited by 35

The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys

Lawrence, M. S., Redmond, D. E., Elsworth, J. D., Taylor, J. R., & Roth, R. H. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90299-q · Cited by 34

Open Pilot Trial of Ritanserin in Parkinsonism

de Noordhout, A. M., & Delwaide, P. J. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198610000-00010 · Cited by 33

Differential Alteration of Striatal D-1 and D-2 Receptors Induced by the Long-Term Administration of Haloperidol, Sulpiride or Clozapine to Rats

Jenner, P. G., Rupniak, N. M. J., & MARSDEN, C. D. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_21 · Cited by 32

Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease

Pinter, M. M., & Helscher, R. J. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251204 · Cited by 32

Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys

Gerlach, J., & Casey, D. E. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90068-r · Cited by 32

The effect of different types of cortical lesions on drug-induced catalepsy in rats: A pharmacological analysis

Worms, P., Willigens, M. T., Continsouza-Blanc, D., & Lloyd, K. G. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90342-5 · Cited by 31

Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.

Kuoppamäki, M., Seppälä, T. T., Syvälahti, E. K. G., & Hietala, J. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10140-7 · Cited by 31

Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior

Mohammed, A. K., Danysz, W., Ögren, S. O., & Archer, T. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90089-3 · Cited by 30

A double‐blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia

Laux, G., KIieser, E., Schröder, H. G., Dittmann, V., Unterweger, B., Schutert, H., König, P., Schöny, H. W., Bunse, J., & Beckmann, H. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05303.x · Cited by 30

Haloperidol and clozapine treatment and their effect onM-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine

Kahn, R. S., Siever, L. J., Davidson, M., et al. (1993) · Psychopharmacology · doi:10.1007/bf02245012 · Cited by 30

Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment

Ichikawa, J., & Meltzer, H. Y. (1990) · Brain Research · doi:10.1016/0006-8993(90)90532-g · Cited by 29

Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone

Svensson, A. I., Carlsson, M. L., & Carlsson, A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90121-x · Cited by 29

Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy

Parashos, S. A., Marı́n, C., & Chase, T. N. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90031-1 · Cited by 29

B-HT920 - A Novel Dopamine Autoreceptor Agonist in the Treatment of Patients with Schizophrenia

Wiedemann, K., Benkert, O., & Holsboer, F. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014482 · Cited by 29

Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry

Maidment, N. T., & Marsden, C. A. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90705-9 · Cited by 28

3-methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC

Groppetti, A., Parenti, M. D., Galli, C. L., Bugatti, A., Cattabeni, F., Giulio, A. M. D., & Racagni, G. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90105-4 · Cited by 27

Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat

Kafetzopoulos, E. (1986) · Psychopharmacology · doi:10.1007/bf00180823 · Cited by 27

Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates.

Casey, D. E. (1989) · PubMed · Cited by 27

A double‐blind multicentre comparison of remoxipride, at two dose levels, and haloperidol

Patris, M., Agussol, P., Alby, J. M., Brion, S., Burnat, G., Castelnau, D., Deluermoz, S., Dufour, H., Ferreri, M., Goudemand, M., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05294.x · Cited by 26

Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.

Simiand, J., Keane, P. E., Barnouin, M. C., et al. (1993) · PubMed · Cited by 26

D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity

Marin, C., Parashos, S. A., Kapitzoglou-Logothetis, V., Peppe, A., & Chase, T. N. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90104-2 · Cited by 25

D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors

Qin, Z., Zhou, L.-W., & Weiss, B. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90206-2 · Cited by 25

Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion

Moore, S., & Kenyon, P. (1994) · Psychopharmacology · doi:10.1007/bf02245453 · Cited by 25

Molecular Neuro Anatomic Mechanisms of Parkinson’s Disease: A Proposed Therapeutic Approach

Gerfen, C. R., & Engber, T. M. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30220-2 · Cited by 25

INFLUENCE OF α1‐ADRENOCEPTOR ANTAGONISM OF KETANSERIN ON THE NATURE OF ITS 5‐HT2 RECEPTOR ANTAGONISM

Marwood, J. F. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02657.x · Cited by 24

Remoxipride and haloperidol in schizophrenia: a double‐blind multicentre study.

Ahlfors, U. G., Rimón, R., Appelberg, B., Hagert, U., Harma, P., Katila, H., Mahlanen, A., Mehtonen, O., Naukkarinen, H., Outakoski, J., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05298.x · Cited by 24

Clozapine improves dizocilpine-induced delayed alternation impairment in rats

Hauber, W. (1993) · Journal of Neural Transmission · doi:10.1007/bf01277027 · Cited by 24

Electrophysiological evidence that intrastriatally administered N-methyl-D-aspartate augments striatal dopamine tone in the rat

Overton, P. G., & Clark, D. T. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257617 · Cited by 23

Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients

den Boer, J. A., Ravelli, D. P., Huisman, J., Öhrvik, J., Verhoeven, W. M. A., & Westenberg, H. G. M. (1990) · Psychopharmacology · doi:10.1007/bf02245748 · Cited by 23

Controlled single blind cross-over study of Ritanserin and placebo in L-Dopa induced dyskinesias in Parkinson's disease

Meco, G., Marini, S., Lestingi, L., Linfante, I., Modarelli, F., & AGNOLI, A. (1988) · Current Therapeutic Research · Cited by 23

Effect of ritanserin, a selective serotonin-S2 antagonist, on parkinsonian rest tremor

Hildebrand, J. G., & Delecluse, F. (1987) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 22

The Effect of OPC-4392, a Partial Dopamine Receptor Agonist on Negative Symptoms: Results of an Open Study

Gerbaldo, H., Demisch, L., Lehmann, C., & Bochnik, J. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1017020 · Cited by 22

Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats

Tucci, S. A., Fernandez, R., Baptista, T., Murzi, E., & Hernandez, L. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90092-2 · Cited by 22

Opposite Regulation of Serotonin-S2and Dopamine-D2Receptors in Rat Brain Following Chronic Receptor Blockade

Leysen, J. E., Gompel, P. V., de Courcelles, D. D. C., & Niemegeers, C. J. E. (1987) · Journal of Receptor Research · doi:10.3109/10799898709054987 · Cited by 22

Effects of dopamine receptor stimulants on locomotor activity of rats with electrolytic or 6-hydroxydopamine-induced lesions of the nucleus accumbens

Woodruff, G. N., Kelly, P. H., & Elkhawad, A. O. (1976) · Psychopharmacology · doi:10.1007/bf00735821 · Cited by 22

Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine

Kahn, R., Davidson, M., Siever, L. J., Sevy, S. M., & Davis, K. L. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91236-x · Cited by 21

Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo

Sumiyoshi, T., Kido, H., Sakamoto, H., Urasaki, K., Suzuki, K., Yamaguchi, N., Mori, H., & Shiba, K. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90471-5 · Cited by 21

Studies on the role of catecholamines in the frontal cortex [proceedings].

Carter, C., & PYCOCK, C. (1978) · PubMed · Cited by 21

Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390

Goldstein, J. M., & Litwin, L. C. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90419-0 · Cited by 20

Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.

Rh, R., Ng, B., Bustos, G. A., & Redmond, D. E. (1980) · PubMed · Cited by 19

A double‐blind comparative multicentre study of remoxipride and haloperidol in schizophrenia

Lindström, L., Wiesekjren, I. ‐., Struwe, G., Kristjansson, E., Akselsorn, S., Arthur, H., Andersen, T., Lindgren, S., Norman, Q., Naimell, L., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05304.x · Cited by 19

A double‐blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia

McCreadie, R. G., Todd, N., Livingston, M., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05305.x · Cited by 19

Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics

Halperin, R., Guerin, J. J., & Davis, K. L. (1989) · Psychopharmacology · doi:10.1007/bf00451692 · Cited by 18

Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat

Antoniou, K. M., & Kafetzopoulos, E. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90399-z · Cited by 18

PARTIAL BENZODIAZEPINE AGONISTS IN SCHIZOPHRENIA: EXPECTATIONS AND PRESENT CLINICAL FINDINGS

Delini‐Stula, A., Berdah-Tordjman, D., & Neumann, N.-U. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00211 · Cited by 17

Effects of lesions in the ventral noradrenergic bundle on behavior and response to psychotropic drugs in rats

Jerlicz, M., Kostowski, W., Bidziński, A., & Hauptmann, M. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90346-5 · Cited by 16

Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic postsynaptic receptors

Lefur, G., Burgevin, M., Malgouris, C., & Uzan, A. (1979) · Neuropharmacology · doi:10.1016/0028-3908(79)90109-6 · Cited by 16

A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia

Andersen, J., Kørner, A., Østergård, P., Fensbo, C., Birket‐Smith, M., Thiesen, S., Hansen, N. R., Fogh, M., Kristensen, M., Møller‐Nielsen, E. M., et al. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05299.x · Cited by 15

Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties

Uzan, A., Fur, G. L., Mitrani, N., Kabouche, M., & DONADIEU, A.-M. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90314-4 · Cited by 15

Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients

Duval, F., Mokrani, M. C., Macher, J. P., Crocq, M. A., Castro, J. O., Bailey, P., & Lataste, X. (1993) · Psychopharmacology · doi:10.1007/bf02246969 · Cited by 15

Remoxipride and haloperidol in the acute phase of schizophrenia: a double‐blind comparison

Deo, R., Soni, S. D., Rastogi, S., Levine, S., PIant, I., Edwards, J. G., Mitchell, M. J., & Chanas, A. C. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05302.x · Cited by 14

Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats

Invernizzi, R. W., Pozzi, L., & SAMANIN, R. (1995) · Brain Research · doi:10.1016/0006-8993(94)01301-w · Cited by 13

The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166

Prinssen, E. P. M., Ellenbroek, B. A., Stamatovic, B., & Cools, A. R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90460-y · Cited by 11

The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin

Edwards, E., Ashby, C. R., & Wang, R. Y. (1991) · Brain Research · doi:10.1016/0006-8993(91)91296-d · Cited by 11

Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen

Jian-ping, C., Paredes, W. M., van Praag, H. M., & Gardner, E. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)90335-7 · Cited by 11

[Changes in the serotonin system of the brains of rats genetically predisposed to catalepsy].

Nk, P., Kulikov, A. V., Колпаков, В. Г., Barykina, N. N., & Alekhina, T. A. (1985) · PubMed · Cited by 11

Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine

Jaskiw, G. E., Hussain, G., & Meltzer, H. Y. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90390-y · Cited by 8

L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophrenia

Owens, D. G. C., Harrison-Read, P. E., & Johnstone, E. C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800403 · Cited by 4

Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: Preliminary findings with risperidone

Bersani, G., Venturi, P., Tanfani, G., & Pancheri, P. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100109 · Cited by 3

CSF NORADRENERGIC ACTIVITY AND SLEEP EEG IN CLINICALLY STABLE SCHIZOPHRENIC PATIENTS AFTER HALOPERIDOL WITHDRAWAL.

van Kammen, D. P., Yao, J., Gurklis, J. A., OʼCONNOR, D., Nofzinger, E. A., & PETERS, J. L. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00168 · Cited by 1

Does Fast Dissociation From the Dopamine D 2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140

The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics

Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.003 · Cited by 882

Schizophrenia, dopamine and the striatum: From biology to symptoms

McCutcheon, R. A., Abi-Dargham, A., & Howes, O. D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.12.004 · Cited by 763

The reinterpretation of dreams: An evolutionary hypothesis of the function of dreaming

Revonsuo, A. (2000) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004015 · Cited by 676

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391